Therefore, in the envisioned strategy, Adriouch team aims to use viral vectors, akin to AAV, to induce ICD intratumorally by expressing active truncated/mutated forms of GSDMD, GSDME or MLKL, thus bypassing tumor resistance to the induction of pyroptosis or necroptosis. The gene discussed is MLKL; the disease is neoplasm.